ATXI CIK: 1644963

Avenue Therapeutics Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.75
FY22:
−7.60
FY23:
−9.45
FY24:
−9.03
FY25:
−1.83
millions USD
FY21:
–
FY22:
0
FY23:
−3.00
FY24:
0
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
4.38
FY22:
10.5
FY23:
7.53
FY24:
9.84
FY25:
2.09

All amounts in millions USD Data source:SEC EDGAR